Cite
McAleavy M, Zhang Q, Ehmann PJ, et al. The Activin/FLRG pathway associates with poor COVID-19 outcomes in hospitalized patients. Mol Cell Biol. 2021;MCB0046721doi: 10.1128/MCB.00467-21.
McAleavy, M., Zhang, Q., Ehmann, P. J., Xu, J., Wipperman, M. F., Ajithdoss, D., Pan, L., Wakai, M., Simonson, R., Gadi, A., Oyejide, A., Hamon, S. C., Boyapati, A., Morton, L. G., Shavlakadze, T., Kyratsous, C. A., & Glass, D. J. (2021). The Activin/FLRG pathway associates with poor COVID-19 outcomes in hospitalized patients. Molecular and cellular biology, MCB0046721. https://doi.org/10.1128/MCB.00467-21
McAleavy, Megan, et al. "The Activin/FLRG pathway associates with poor COVID-19 outcomes in hospitalized patients." Molecular and cellular biology vol. (2021): MCB0046721. doi: https://doi.org/10.1128/MCB.00467-21
McAleavy M, Zhang Q, Ehmann PJ, Xu J, Wipperman MF, Ajithdoss D, Pan L, Wakai M, Simonson R, Gadi A, Oyejide A, Hamon SC, Boyapati A, Morton LG, Shavlakadze T, Kyratsous CA, Glass DJ. The Activin/FLRG pathway associates with poor COVID-19 outcomes in hospitalized patients. Mol Cell Biol. 2021 Nov 01;MCB0046721. doi: 10.1128/MCB.00467-21. Epub 2021 Nov 01. PMID: 34723652.
Copy
Download .nbib